Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.2K Buy
+1,330
New +$37.4K ﹤0.01% 720
2026
Q1
Sell
-295
Closed -$11.7K 1455
2025
Q4
$11.7K Buy
295
+193
+189% +$7.08K ﹤0.01% 1318
2025
Q3
$3.6K Sell
102
-56
-35% -$1.93K ﹤0.01% 1900
2025
Q2
$5.18K Sell
158
-200
-56% -$6.5K ﹤0.01% 1455
2025
Q1
$11.5K Sell
358
-21
-6% -$780 ﹤0.01% 1242
2024
Q4
$11.6K Buy
+379
New +$12.2K ﹤0.01% 1238
2024
Q3
Sell
-451
Closed -$10.3K 1638
2024
Q2
$10.3K Buy
451
+284
+170% +$6.55K ﹤0.01% 1316
2024
Q1
$5.08K Buy
+167
New +$5.59K ﹤0.01% 1334
2023
Q4
Sell
-102
Closed -$4.47K 1386
2023
Q3
$4.47K Buy
+102
New +$4.98K ﹤0.01% 1024
2023
Q2
Sell
-490
Closed -$20.3K 1061
2023
Q1
$20.3K Buy
+490
New +$20.3K ﹤0.01% 651

Other funds holding ATRC

Quarry LP's ATRC Position: Q2 2026 in Review

Quarry LP opened a new position in AtriCure (ATRC) in Q2 2026: 1,330 shares worth $37.2K. The stake represents ﹤0.01% of the portfolio and ranks #720 among its holdings. This is a return to the name: Quarry LP previously reported a position in ATRC as recently as Q4 2025.

Quarry LP first reported a position in ATRC in Q1 2023 and has held it in 10 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Quarry LP held 1,330 shares of AtriCure worth $37.2K as of Q2 2026.
  • AtriCure was a new Quarry LP position in Q2 2026.
  • AtriCure made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #720 holding.
  • Quarry LP first reported a position in AtriCure in Q1 2023 and has held it in 10 quarters since.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.